ONWARD Medical develops implantable and external spinal cord stimulation systems (ARC Therapy) to restore motor function in spinal cord injury patients. The tech stack—Python, MATLAB, Java, .NET, Android—reflects a medical-device software operation handling both embedded systems (implantable devices) and mobile/cloud connectivity. Active hiring across engineering, manufacturing, and research, concentrated in Switzerland and the US, indicates scaling toward clinical trials and regulatory submission; the project list confirms this trajectory: pivotal clinical study protocols, medical device software subsystems, and cloud deployment infrastructure are all active.
ONWARD Medical is a publicly traded medical technology company headquartered in Eindhoven, Netherlands, with a Science and Engineering Center in Lausanne, Switzerland, and expanding US operations. The company develops ARC Therapy—a targeted spinal cord stimulation treatment delivered via implantable or external systems—designed to restore movement and independence in people with spinal cord injuries. The work builds on over a decade of preclinical research conducted at leading neuroscience laboratories and is backed by an academic partnership with NeuroRestore, a joint initiative between EPFL and Lausanne University Hospital. The organization spans 51–200 employees and is actively advancing toward regulatory milestones.
ARC Therapy, a programmable spinal cord stimulation system available in implantable (ARC-IM) and external (ARC-EX) forms, designed to restore movement and function in spinal cord injury patients.
Python, MATLAB, Java, .NET, C#, Android, Kotlin, and SAP. The mix of simulation (MATLAB), mobile development (Android/Kotlin), backend systems (.NET/Java), and enterprise resource planning (SAP) supports embedded device development and clinical trial management.
Other companies in the same industry, closest in size